GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Quick Ratio

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Quick Ratio : 0.16 (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Biostar Pharmaceuticals's quick ratio for the quarter that ended in Sep. 2017 was 0.16.

Biostar Pharmaceuticals has a quick ratio of 0.16. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Biostar Pharmaceuticals's Quick Ratio or its related term are showing as below:

BSPM's Quick Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.33
* Ranked among companies with meaningful Quick Ratio only.

Biostar Pharmaceuticals Quick Ratio Historical Data

The historical data trend for Biostar Pharmaceuticals's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Quick Ratio Chart

Biostar Pharmaceuticals Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.24 7.34 4.82 2.24 1.28

Biostar Pharmaceuticals Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.28 1.16 0.14 0.16

Competitive Comparison of Biostar Pharmaceuticals's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostar Pharmaceuticals's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's Quick Ratio falls into.



Biostar Pharmaceuticals Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Biostar Pharmaceuticals's Quick Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Quick Ratio (A: Dec. 2016 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(7.365-0.167)/5.623
=1.28

Biostar Pharmaceuticals's Quick Ratio for the quarter that ended in Sep. 2017 is calculated as

Quick Ratio (Q: Sep. 2017 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.997-0.171)/5.279
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biostar Pharmaceuticals  (OTCPK:BSPM) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Biostar Pharmaceuticals Quick Ratio Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines